April 2020
65 articles-
Apr 30 · 00:31Biotechnology Daily
Thrive's early blood test doubles real-world cancer screening rates
-
Apr 30 · 00:22Bio Business News
Taysha Gene Therapies hits the ground running with $30M, 15 programs
-
Apr 29 · 00:52Biotechnology Daily
Early Syndax data broach 'undruggable' leukemia mutation
-
Apr 29 · 00:49Biotechnology Daily
Iovance details early responses to TIL cell therapy in lung cancer
-
Apr 29 · 00:44Bio Business News
Roche shares SMA data ahead of scrap with Biogen, Novartis
-
Apr 28 · 01:45Biotechnology Daily
Grail substudy shows its cancer blood test could help focus oncologists' diagnostic work-ups
-
Apr 28 · 01:42Biotechnology Daily
Early Trovagene data offer hope for KRAS-mutant colon cancer
-
Apr 28 · 01:38Biotechnology Daily
A look at next-gen CAR-T therapies for blood cancers
-
Apr 28 · 01:35Bio Business News
Compugen's checkpoint inhibitor keeps cancer in check
-
Apr 28 · 01:18Bio Business News
Rome Therapeutics debuts with $50M and Rosana Kapeller at the helm
-
Apr 28 · 01:03Market Watch
Tesla stock rallies on hopes factory reopen is around the corner
-
Apr 27 · 07:44Biotechnology Daily
Working backward, a brain-computer interface returns a sense of touch after complete spinal cord injury
-
Apr 27 · 07:43Biotechnology Daily
Veracyte to couple Yale genomic test with its pulmonary fibrosis diagnostic
-
Apr 27 · 07:42Biotechnology Daily
Healing the heart by returning it to its infancy
-
Apr 27 · 07:40Bio Business News
GSK posts middling data from PD-1 Tesaro buyout drug
-
Apr 27 · 07:38Bio Business News
Takeda licenses ProThera plasma drug for use in inflammatory conditions
-
Apr 27 · 06:57Market Watch
Boeing ends deal with Embraer, Brazilian jet maker threatens legal action
-
Apr 24 · 07:57Biotechnology Daily
Sanofi posts data from contentious phase 2 multiple sclerosis trial
-
Apr 24 · 07:47Bio Business News
Accent Therapeutics nabs $63M for RNA cancer push
-
Apr 22 · 23:57Bio Business News
AbbVie, Sofinnova back $38M round for Parkinson’s-focused Nitrome
-
Apr 22 · 23:55Bio Business News
Shawver takes the wheel at I-O biotech Silverback Therapeutics
-
Apr 22 · 23:48Bio Business News
Myovant's endometriosis med hits the mark in phase 3, setting up AbbVie face-off
-
Apr 22 · 08:57Bio Business News
Novartis ventures again into digital therapeutics with 'lazy eye' video game buy and collabs with Ubisoft, McGill
-
Apr 22 · 07:37Bio Business News
Scynexis' new antifungal on track for 2020 filing with phase 3 win